Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Elaine, Harstead"'
Autor:
Clinton F. Stewart, Burgess B. Freeman, Stacy L. Throm, K. Elaine Harstead, David M. Loeb, Jennifer Reikes Willert, Bhaskar Rao, Michael Neel, Victor M. Santana, Jianrong Wu, Shenghua Mao, Najat C. Daw, Fariba Navid, David C. Turner
Purpose: To describe sources of interindividual variability in bevacizumab disposition in pediatric patients and explore associations among bevacizumab pharmacokinetics and clinical wound healing outcomes.Experimental Design: Before tumor resection,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c735d08d71518fd443f7e25a1e9a5a5e
https://doi.org/10.1158/1078-0432.c.6521471.v1
https://doi.org/10.1158/1078-0432.c.6521471.v1
Autor:
Clinton F. Stewart, Burgess B. Freeman, Stacy L. Throm, K. Elaine Harstead, David M. Loeb, Jennifer Reikes Willert, Bhaskar Rao, Michael Neel, Victor M. Santana, Jianrong Wu, Shenghua Mao, Najat C. Daw, Fariba Navid, David C. Turner
PDF file - 200K, Supplementary Table 1. Comparison of predictive performance for model parameterizations A, (B), and C (with IBW covariate) Supplemental Figure 1. The base structural bevacizumab model consisted of a two compartment model parameterize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b2018329160909b9d070253b4a6cefe
https://doi.org/10.1158/1078-0432.22448723
https://doi.org/10.1158/1078-0432.22448723
Autor:
Amanda Lipsitt, Lisa Beattie, Elaine Harstead, Ying Li, Salil Goorha, Gabriela Maron, Stephen Gottschalk, Brandon Triplett, Swati Naik
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db39647dfe61be2a9aa6860c846c2885
https://doi.org/10.1002/pbc.30166
https://doi.org/10.1002/pbc.30166
Autor:
Amanda, Lipsitt, Lisa, Beattie, Elaine, Harstead, Ying, Li, Salil, Goorha, Gabriela, Maron, Stephen, Gottschalk, Brandon, Triplett, Swati, Naik
Publikováno v:
Pediatric bloodcancerREFERENCES.
Hematological toxicity (hematotoxicity) leading to peripheral cytopenias is a common long-term adverse effect following the use of CD19-chimeric antigen receptor (CD19-CAR) T-cell therapies. However, management remains unclear for patients whose cyto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6de0c2af858b80c67be5c0619f392952
https://pubmed.ncbi.nlm.nih.gov/36565276
https://pubmed.ncbi.nlm.nih.gov/36565276
Autor:
Amanda Lipsitt, Lisa Beattie, Elaine Harstead, Ying Li, Salil Goorha, Gabriela Maron, Stephen Gottschalk, Brandon Triplett, Swati Naik
Hematological toxicity (hematotoxicity) is the most common long-term adverse effect following the use of CD19-chimeric antigen receptor (CD19-CAR) T-cell therapies. However, its management remains unclear. We present the case of a 21-year-old who rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::577f8ff1f345a4c9cd0a0b978544bba3
https://doi.org/10.22541/au.166315142.27403264/v1
https://doi.org/10.22541/au.166315142.27403264/v1
Autor:
Swati Naik, Renee M. Madden, Amanda Lipsitt, Timothy Lockey, Jennyfer Bran, Jeffrey E. Rubnitz, Jeffery Klco, Barry Shulkin, Sagar L. Patil, Sarah Schell, Jeoungeun John Park, Janice Riberdy, Na Shang, Jaquelyn T. Zoine, Jennifer Wallace, Elaine Harstead, Catherine Willis, Jean-Yves Metais, Deanna M. Langfitt, Sheng Zhou, Salem M. Akel, Michael M. Meagher, Brandon M. Triplett, Stephen Gottschalk, Mireya Paulina Velasquez
Publikováno v:
Blood. 140:4584-4585
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83d23c5ea62f92a755cb49df7675df8c
https://doi.org/10.1182/blood-2022-170201
https://doi.org/10.1182/blood-2022-170201
Autor:
Saman K Hashmi, Aimee C Talleur, Brandon M. Triplett, Dennis Black, Ian Clark, Elaine Harstead, Mansi Sachdev, Ibrahim Ortanca
Publikováno v:
Pediatric Transplantation. 25
Background EPP is a rare disorder of heme biosynthesis in which patients present with disabling photosensitivity. A subset of patients develop severe liver disease with progressive liver failure necessitating an OLT. A HCT can potentially cure EPP by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f131205de07c914b19570083553481b6
https://doi.org/10.1111/petr.13966
https://doi.org/10.1111/petr.13966
Autor:
Tong Lin, Giles W. Robinson, Vinay M. Daryani, Yogesh T. Patel, Olivia Campagne, K. Elaine Harstead, Jessica K. Roberts, Clinton F. Stewart, Jie Huang, Arzu Onar-Thomas, Alberto Broniscer, John C. Panetta, Deborah A. Ward, Amar Gajjar
Publikováno v:
Br J Clin Pharmacol
AIMS: No population pharmacokinetic studies of high‐dose methotrexate (HDMTX) have been conducted in infants with brain tumours, which are a vulnerable population. The aim of this study was to evaluate HDMTX disposition in these children to provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf8502217c4dbbfcdad74893aef3233
https://pubmed.ncbi.nlm.nih.gov/31657864
https://pubmed.ncbi.nlm.nih.gov/31657864
Autor:
Vinay M. Daryani, Nicholas S. Selvo, Michael S. Roberts, Jessica K. Roberts, Amar Gajjar, Clinton F. Stewart, Thandranese S. Owens, K. Elaine Harstead
Publikováno v:
Journal of Liquid Chromatography & Related Technologies. 39:745-751
A rapid and robust method for measuring methotrexate (MTX) and its two primary metabolites, 7-hydroxymethotrexate (7-OHMTX) and 2,4-diamino-N10-methylpteroic acid (DAMPA), was developed for use in pharmacokinetic studies of plasma and cerebrospinal f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5e1ce12a0cca68c1f07f2028d33dbf8
https://doi.org/10.1080/10826076.2016.1243558
https://doi.org/10.1080/10826076.2016.1243558
Autor:
Vinay M. Daryani, K. Elaine Harstead, Yogesh T. Patel, Clinton F. Stewart, Megan O. Jacus, Stacy L. Throm
Publikováno v:
Clinical Pharmacokinetics. 55:297-311
Despite significant improvement in outcomes for patients with hematologic malignancies and solid tumors over the past 10 years, patients with primary or metastatic brain tumors continue to have a poor prognosis. A primary reason for this is the inabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0efa15e37fb45c9a86b3ec0f391ea9e4
https://doi.org/10.1007/s40262-015-0319-6
https://doi.org/10.1007/s40262-015-0319-6